{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:42:02Z","timestamp":1758044522182,"version":"3.44.0"},"reference-count":192,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128180846"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/b978-0-12-818084-6.00009-x","type":"book-chapter","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T06:48:00Z","timestamp":1592549280000},"page":"333-374","source":"Crossref","is-referenced-by-count":0,"title":["Toward the therapeutic application of small interfering RNA bioconjugates in the central nervous system"],"prefix":"10.1016","author":[{"given":"Jo\u00e3o","family":"Cortinhas","sequence":"first","affiliation":[]},{"given":"Ana P.","family":"P\u00eago","sequence":"additional","affiliation":[]},{"given":"Pedro M.D.","family":"Moreno","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib2","first-page":"111","article-title":"Neurological disorders associated with malnutrition","author":"World Health Organization (WHO)","year":"2014","journal-title":"Neurol. Disord. Public. Heal. Chall."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib3","series-title":"Brain Damage\u2014Bridg. Between Basic Res. Clin","first-page":"1","article-title":"Pathology of neurodegenerative diseases","author":"Kim","year":"2012"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11481-007-9099-6","article-title":"Novel nanomaterials for clinical neuroscience","volume":"3","author":"Gilmore","year":"2008","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pneurobio.2016.11.001","article-title":"The Yin and Yang of nucleic acid-based therapy in the brain","volume":"155","author":"Gustincich","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.surneu.2004.06.008","article-title":"Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system","volume":"63","author":"Silva","year":"2005","journal-title":"Surg. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature20412","article-title":"The road to restoring neural circuits for the treatment of Alzheimer\u2019s disease","volume":"539","author":"Canter","year":"2016","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature20414","article-title":"Defects in trafficking bridge Parkinson\u2019s disease pathology and genetics","volume":"539","author":"Abeliovich","year":"2016","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib10","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-007-9324-2","article-title":"Drug targeting to the brain","volume":"24","author":"Pardridge","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib12","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2174\/138161211797440221","article-title":"The ABC of the blood-brain barrier\u2014regulation of drug efflux pumps","volume":"17","author":"Mahringer","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/092986710790827816","article-title":"Transporters in the brain endothelial barrier","volume":"17","author":"Ueno","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.06.002","article-title":"PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier","volume":"211","author":"Fornaguera","year":"2015","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","article-title":"Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting","volume":"24","author":"Singh","year":"2016","journal-title":"J. Drug. Target."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib16","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3109\/10717544.2015.1089956","article-title":"Galantamine-loaded solid\u2013lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations","volume":"23","author":"Misra","year":"2016","journal-title":"Drug. Deliv."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc034164r","article-title":"Nanogels for oligonucleotide delivery to the brain","volume":"15","author":"Vinogradov","year":"2004","journal-title":"Bioconjug Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jps.24222","article-title":"PAMAM dendrimers: destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applications","volume":"104","author":"Labieniec-Watala","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood\u2013brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clineuro.2014.05.024","article-title":"Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia","volume":"123","author":"Margetis","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2019.06.007","article-title":"From clinical trials to clinical practice: practical considerations for gene replacement therapy in SMA type 1","author":"Al-Zaidy","year":"2019","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/papr.12111","article-title":"Intrathecal drug administration in chronic pain syndromes","volume":"14","author":"Ver Donck","year":"2014","journal-title":"Pain. Pract."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jemermed.2017.01.020","article-title":"Review of intranasally administered medications for use in the emergency department","volume":"53","author":"Bailey","year":"2017","journal-title":"J. Emerg. Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","author":"Agrawal","year":"2018","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2015.12.013","article-title":"Targeting specific cells in the brain with nanomedicines for CNS therapies","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib30","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/mtna.2013.65","article-title":"Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain","volume":"2","author":"Rungta","year":"2013","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib32","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1016\/j.biomaterials.2013.08.045","article-title":"Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery","volume":"34","author":"Chu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1039\/C5MD00038F","article-title":"Selective neuronal targeting, protection and signaling network analysis via dopamine-mediated mesoporous silica nanoparticles","volume":"6","author":"Zhang","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0167-7799(90)90220-R","article-title":"Altered gene expression in plants due to trans interactions between homologous genes","volume":"8","author":"Jorgensen","year":"1990","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib36","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/bioinformatics\/btu202","article-title":"ThunderSTORM: a comprehensive imageJ plug-in for PALM and STORM data analysis and super-resolution imaging","volume":"30","author":"Ovesn\u00fd","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80620-0","article-title":"RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals","volume":"101","author":"Zamore","year":"2000","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib40","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.R900012200","article-title":"The RNA-induced silencing complex: a versatile gene-silencing machine","volume":"284","author":"Pratt","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/MMBR.68.3.432-452.2004","article-title":"Effects of length and location on the cellular response to double-stranded RNA","volume":"68","author":"Wang","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib44","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/nl1016909","article-title":"Chitosan\/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth","volume":"10","author":"Mittnacht","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib45","doi-asserted-by":"crossref","DOI":"10.1515\/rnan-2016-0003","article-title":"Non-viral vector mediated RNA interference technology for central nervous system injury","volume":"3","author":"Macks","year":"2016","journal-title":"DNA RNA Nanotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cgt.2016.4","article-title":"Precise and efficient siRNA design: a key point in competent gene silencing","volume":"23","author":"Fakhr","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1261\/rna.5239604","article-title":"In vivo activity of nuclease-resistant siRNAs","volume":"10","author":"Layzer","year":"2004","journal-title":"RNA"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/B611612D","article-title":"MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity","volume":"3","author":"Turner","year":"2007","journal-title":"Mol. Biosyst."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cbic.201200611","article-title":"Functionalization of the 3\u2032-ends of DNA and RNA strands with N-ethyl-N-coupled nucleosides: a promising approach to avoid 3\u2032-exonuclease-catalyzed hydrolysis of therapeutic oligonucleotides","volume":"14","author":"Terrazas","year":"2013","journal-title":"Chem Bio Chem"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib50","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.106.009555","article-title":"Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules","volume":"34","author":"Van De Water","year":"2006","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib51","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib52","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2967\/jnumed.109.069906","article-title":"Noninvasive visualization of RNA delivery with 99mTc- radiolabeled small-interference RNA in tumor xenografts","volume":"51","author":"Kang","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/17425247.2014.896898","article-title":"Advances in targeted delivery of small interfering RNA using simple bioconjugates","volume":"11","author":"Nielsen","year":"2014","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-chembioeng-061010-114133","article-title":"Silencing or stimulation? siRNA delivery and the immune system","volume":"2","author":"Whitehead","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib55","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-\u03baB by toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib57","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/jcb.20716","article-title":"siRNA binding proteins of microglial cells: PKR is an unanticipated ligand","volume":"97","author":"Zhang","year":"2006","journal-title":"J. Cell Biochem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nbt1205","article-title":"A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells","volume":"24","author":"Marques","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in advanced drug delivery reviews 23 (1997)","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/nat.2013.0463","article-title":"Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology","volume":"24","author":"Juliano","year":"2014","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib62","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/med.21479","article-title":"Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy","volume":"38","author":"Chen","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chembiol.2012.07.011","article-title":"Designing chemically modified oligonucleotides for targeted gene silencing","volume":"19","author":"Deleavey","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib64","first-page":"2","article-title":"Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic","author":"Moreno","year":"2014","journal-title":"Front. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib65","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nature08434","article-title":"Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes","volume":"461","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib66","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.93.19.10018","article-title":"On the mechanism of action of ribonuclease A: relevance of enzymatic studies with a p-nitrophenylphosphate ester and a thiophosphate ester","volume":"93","author":"Breslow","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib67","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/190781a0","article-title":"The active site and mechanism of action of bovine pancreatic ribonuclease","volume":"190","author":"Findly","year":"1961","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib68","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1093\/emboj\/20.14.3617","article-title":"Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs","volume":"20","author":"Kiss","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/oli.2008.0162","article-title":"Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect","volume":"19","author":"Volkov","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib70","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cbpa.2004.10.007","article-title":"RNA interference and chemically modified small interfering RNAs","volume":"8","author":"Manoharan","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2005.11.002","article-title":"Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib72","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/nar\/23.11.2019","article-title":"Characterization of fully 2\u2019-modified oligoribonucleotide hetero-and homoduplex hybridization and nuclease sensitivity","volume":"23","author":"Cummins","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gnh044","article-title":"siRNA relieves chronic neuropathic pain","volume":"32","author":"Dorn","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib74","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/jm050044o","article-title":"Positional effect of chemical modifications on short interference RNA activity in mammalian cells","volume":"48","author":"Prakash","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","article-title":"Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA","volume":"8","author":"Braasch","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/nar\/gki193","article-title":"Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality","volume":"33","author":"Elm\u00e9n","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","article-title":"Sequence-specific potent induction of IFN-\u03b1 by short interfering RNA in plasmacytoid dendritic cells through TLR7","volume":"11","author":"Hornung","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib78","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/nar\/gkg393","article-title":"Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells","volume":"31","author":"Czauderna","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib79","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1093\/nar\/gkv298","article-title":"2\u2032-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF","volume":"43","author":"Shen","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib80","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/nar\/gky060","article-title":"Acute hepatotoxicity of 2 fluoro-modified 5\u201310\u20135 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib81","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.2174\/138161208786898798","article-title":"siRNA modifications and sub-cellular localization: a question of intracellular transport?","volume":"14","author":"Ohrt","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib82","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/nar\/gkz140","article-title":"Safety evaluation of 2\u2019-deoxy-2\u2019-fluoro nucleotides in GalNAc-siRNA conjugates","volume":"47","author":"Janas","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib83","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/jm049167j","article-title":"Fully 2\u2032-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA","volume":"48","author":"Allerson","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib84","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/nar\/gky037","article-title":"Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo","volume":"46","author":"Hassler","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib85","doi-asserted-by":"crossref","DOI":"10.1021\/ja00718a039","article-title":"Nucleoside phosphorothioates","author":"Eckstein","year":"1970","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib86","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","volume":"24","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib87","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/nar\/gky145","article-title":"Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-019-0205-0","article-title":"A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system","author":"Alterman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib89","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt.3078","article-title":"Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications","volume":"32","author":"Meade","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib90","first-page":"1469","article-title":"Phosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analyses","volume":"45","author":"Trubetskoy","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib91","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/nar\/gkw1171","article-title":"SiRNA carrying an (E)-vinylphosphonate moiety at the 5\u2019 end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2","volume":"45","author":"Elkayam","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd3010","article-title":"Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application","volume":"9","author":"Jackson","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib93","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(03)01492-3","article-title":"Enhancement of RNAi activity by improved siRNA duplexes","volume":"557","author":"Hohjoh","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib96","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1093\/nar\/gkm548","article-title":"Improved silencing properties using small internally segmented interfering RNAs","volume":"35","author":"Bramsen","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib97","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","article-title":"Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy","volume":"23","author":"Kim","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib98","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1093\/nar\/gki732","article-title":"Functional polarity is introduced by dicer processing of short substrate RNAs","volume":"33","author":"Rose","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.2008.0123","article-title":"Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs","volume":"18","author":"Collingwood","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nbt1052","article-title":"Synthetic shRNAs as potent RNAi triggers","volume":"23","author":"Siolas","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib101","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1021\/ja0754453","article-title":"Dumbbell-shaped nanocircular RNAs for RNA interference","volume":"129","author":"Abe","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib102","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.febslet.2014.02.015","article-title":"42- and 63-bp anti-MDR1-siRNAs bearing 2\u2032-OMe modifications in nuclease-sensitive sites induce specific and potent gene silencing","volume":"588","author":"Gvozdeva","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib103","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1873-3468.12927","article-title":"Nuclease-resistant 63-bp trimeric siRNAs simultaneously silence three different genes in tumor cells","volume":"592","author":"Gvozdeva","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib104","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1039\/c1cc11780g","article-title":"Branched RNA nanostructures for RNA interference","volume":"47","author":"Nakashima","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib105","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1039\/C7TB00846E","article-title":"Enhancement of synergistic gene silencing by RNA interference using branched \u201c3-in-1\u201d trimer siRNA","volume":"5","author":"Nair","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib106","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1093\/nar\/25.22.4447","article-title":"Oligonucleotide dendrimers: synthesis and use as polylabelled DNA probes","volume":"25","author":"Shchepinov","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib107","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/nar\/27.15.3035","article-title":"Oligonucleotide dendrimers: stable nano-structures","volume":"27","author":"Shchepinov","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib108","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/hlca.200390232","article-title":"Synthesis of branched oligonucleotides as templates for the assembly of nanomaterials","volume":"86","author":"Grimau","year":"2003","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/586935","article-title":"Branched RNA: a new architecture for RNA interference","volume":"2011","author":"Avi\u00f1\u00f3","year":"2011","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jgm.1653","article-title":"Enhanced intracellular delivery and multi-target gene silencing triggered by tripodal RNA structures","volume":"14","author":"Chang","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib111","doi-asserted-by":"crossref","DOI":"10.1021\/cb501028c","article-title":"siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes","author":"Matsuda","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib112","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nbt1101","article-title":"Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors","volume":"23","author":"Song","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib113","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1093\/nar\/gki991","article-title":"Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 tat-dependent trans-activation in cells","volume":"33","author":"Turner","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib114","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biomaterials.2015.10.075","article-title":"Method of carrier-free delivery of therapeutic RNA importable into human mitochondria: lipophilic conjugates with cleavable bonds","volume":"76","author":"Dovydenko","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/acs.bioconjchem.8b00080","article-title":"Cholesterol-modified caged siRNAs for photoregulating exogenous and endogenous gene expression","volume":"29","author":"Yang","year":"2018","journal-title":"Bioconjug Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib116","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2119\/molmed.2015.00210","article-title":"Novel targeted therapy for precursor B-cell acute lymphoblastic leukemia: anti-CD22 antibody-MXD3 antisense oligonucleotide conjugate","volume":"22","author":"Satake","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib117","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.bmcl.2004.07.018","article-title":"Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells","volume":"14","author":"Lorenz","year":"2004","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/17425247.2018.1473375","article-title":"Recent preclinical and clinical advances in oligonucleotide conjugates","volume":"15","author":"Craig","year":"2018","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib119","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/nar\/28.14.2717","article-title":"Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation","volume":"28","author":"Bijsterbosch","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-2952(01)00705-5","article-title":"Delivery of cholesteryl-conjugated phosphorothioate oligodeoxynucleotides to Kupffer cells by lactosylated low-density lipoprotein","volume":"62","author":"Bijsterbosch","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib122","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/nar\/gky1239","article-title":"Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo","volume":"47","author":"Biscans","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.02.015","article-title":"Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells","volume":"125","author":"Gvozdeva","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib124","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omtn.2016.12.011","article-title":"Cholesterol-containing nuclease-resistant siRNA accumulates in tumors in a carrier-free mode and silences MDR1 gene","volume":"6","author":"Chernikov","year":"2017","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib125","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl Acad. Sci. U S A"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib126","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1038\/mtna.2015.38","article-title":"Hydrophobically modified siRNAs silence huntingtin mRNA in primary neurons and mouse brain","volume":"4","author":"Alterman","year":"2015","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib127","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1038\/mtna.2016.55","article-title":"Silencing myostatin using cholesterol-conjugated siRNAs induces muscle growth","volume":"5","author":"Khan","year":"2016","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"Dyall","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib129","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1038\/mtna.2016.50","article-title":"Docosahexaenoic acid conjugation enhances distribution and safety of siRNA upon local administration in mouse brain","volume":"5","author":"Nikan","year":"2016","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/mt.2008.14","article-title":"Efficient in vivo delivery of siRNA to the liver by conjugation of \u03b1-tocopherol","volume":"16","author":"Nishina","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib131","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1021\/jm2000272","article-title":"Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma","volume":"54","author":"Raouane","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib132","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1093\/nar\/gkr1002","article-title":"Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group","volume":"40","author":"Petrova","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib133","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1476-5381.2009.00288.x","article-title":"Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers","volume":"157","author":"Midoux","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib134","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(03)01505-9","article-title":"Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells","volume":"558","author":"Muratovska","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/bc9801070","article-title":"Efficient gene transfer by histidylated polylysine\/pDNA complexes","volume":"10","author":"Midoux","year":"1999","journal-title":"Bioconjug Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib136","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0142-9612(03)00542-8","article-title":"Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro","volume":"25","author":"Okuda","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib137","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.biomaterials.2008.01.031","article-title":"An endosomolytic tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection","volume":"29","author":"Lo","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib138","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/nat.2012.0389","article-title":"Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo","volume":"22","author":"Wong","year":"2012","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib139","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1073\/pnas.1016152108","article-title":"Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer","volume":"108","author":"Hsu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib140","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/bc070077d","article-title":"Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity","volume":"18","author":"Moschos","year":"2007","journal-title":"Bioconjug Chem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib141","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070507","article-title":"Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study","volume":"407","author":"El-Andaloussi","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib142","first-page":"10","article-title":"Current development of siRNA bioconjugates: from research to the clinic","author":"Chernikov","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib143","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting\u2014strategies and applications","volume":"203","author":"D\u2019Souza","year":"2015","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib144","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.1093\/nar\/gkx818","article-title":"Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates","volume":"45","author":"Nair","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib145","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N -acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib146","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nbt1216-1213","article-title":"Alnylam terminates revusiran program, stock plunges","volume":"34","author":"Garber","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib147","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and clinical advances of GalNAc-decorated nucleic acid therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib148","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1093\/nar\/gku831","article-title":"Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA","volume":"42","author":"Liu","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib149","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1749-6632.2009.04977.x","article-title":"Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues","volume":"1175","author":"Thomas","year":"2009","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib151","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib152","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/mp.2015.80","article-title":"Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration","volume":"21","author":"Ferr\u00e9s-Coy","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib153","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1021\/ja303251f","article-title":"Click-modified anandamide siRNA enables delivery and gene silencing in neuronal and immune cells","volume":"134","author":"Willibald","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib154","doi-asserted-by":"crossref","DOI":"10.1021\/cb200176v","article-title":"Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA","author":"Ma","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.06.036","article-title":"Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles","volume":"237","author":"Sugo","year":"2016","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib156","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1111\/j.1742-4658.2008.06438.x","article-title":"Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold","volume":"275","author":"Nygren","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib157","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.nano.2015.01.017","article-title":"Conformation-dependent binding and tumor-targeted delivery of siRNA by a designed TRBP2: affibody fusion protein","volume":"11","author":"Dar","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib158","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.drudis.2008.04.013","article-title":"DARPins: new generation of protein therapeutics","volume":"13","author":"Stumpp","year":"2008","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib159","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpb.2019.05.015","article-title":"Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: influence of linker stability on gene silencing","volume":"141","author":"Lorenzer","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev.med.56.062904.144915","article-title":"Aptamers: an emerging class of therapeutics","volume":"56","author":"Nimjee","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3001581","article-title":"An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4+ T cell decline in humanized mice","volume":"3","author":"Neff","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib162","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2012.226","article-title":"Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge","volume":"21","author":"Zhou","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib163","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib164","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2016.07.032","article-title":"A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells","volume":"238","author":"Esposito","year":"2016","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib165","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.omtn.2017.12.021","article-title":"STAT3 gene silencing by aptamer-siRNA chimera as selective therapeutic for glioblastoma","volume":"10","author":"Esposito","year":"2018","journal-title":"Mol. Ther.\u2014Nucleic Acids"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib166","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/srep03129","article-title":"A universal protein tag for delivery of SiRNA-aptamer chimeras","volume":"3","author":"Liu","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib167","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1073\/pnas.0703778104","article-title":"Dynamic poly conjugates for targeted in vivo delivery of siRNA to hepatocytes","volume":"104","author":"Rozema","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib168","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2015.04.012","article-title":"Protease-triggered siRNA delivery vehicles","volume":"209","author":"Rozema","year":"2015","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib169","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/mt.2013.31","article-title":"Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection","volume":"21","author":"Wooddell","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2018.03.012","article-title":"Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients","volume":"69","author":"Turner","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib171","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2015.01.007","article-title":"Preclinical and clinical development of siRNA-based therapeutics","volume":"87","author":"Ozcan","year":"2015","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib172","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib173","first-page":"185","article-title":"Biomaterial-based vectors for targeted delivery of nucleic acids to the nervous system","volume":"vol. 4","author":"P\u00eago","year":"2013"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib174","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1557\/mrs.2013.314","article-title":"Translating chitosan to clinical delivery of nucleic acid-based drugs","volume":"39","author":"Gomes","year":"2014","journal-title":"MRS Bull."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib175","doi-asserted-by":"crossref","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib176","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","article-title":"Lipid-based nanoparticle formulations for small molecules and RNA drugs","volume":"16","author":"Ickenstein","year":"2019","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib177","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1073\/pnas.93.21.11493","article-title":"Mechanism of oligonucleotide release from cationic liposomes","volume":"93","author":"Zelphati","year":"1996","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib178","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2012.09.009","article-title":"A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo","volume":"163","author":"Sato","year":"2012","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib179","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jconrel.2014.06.009","article-title":"Quo vadis polyplex?","volume":"190","author":"Merkel","year":"2014","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib181","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10611860400003858","article-title":"Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies","volume":"12","author":"Khan","year":"2004","journal-title":"J. Drug. Target."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib182","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.progpolymsci.2016.09.008","article-title":"Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy","volume":"64","author":"Amjad","year":"2017","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2017.04.008","article-title":"Polymeric nanoparticles for siRNA delivery: production and applications","author":"Cavallaro","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib184","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099449","article-title":"Modified-chitosan\/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier","author":"Sadio","year":"2014","journal-title":"PLOS One"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201700313","article-title":"Dendrimers as powerful building blocks in central nervous system disease: headed for successful nanomedicine","author":"Leiro","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib186","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/ph6020161","article-title":"Dendrimers for siRNA delivery","volume":"6","author":"Biswas","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib187","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1039\/C7TB00279C","article-title":"Biodegradable PEG-dendritic block copolymers: synthesis and biofunctionality assessment as vectors of siRNA","volume":"5","author":"Leiro","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib188","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1566523217666170510160527","article-title":"Delivering siRNA with dendrimers: in vivo applications","volume":"17","author":"Leiro","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib189","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2147\/IJN.S106625","article-title":"Lipid nanoparticles for targeted siRNA delivery\u2014going from bench to bedside","volume":"11","author":"Zatsepin","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/nat.2013.0462","article-title":"Design and application of bispecific splice-switching oligonucleotides","volume":"24","author":"Bestas","year":"2014","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib191","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7150\/thno.5743","article-title":"Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice","volume":"3","author":"Iversen","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/B978-0-12-818084-6.00009-X_bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.02.003","article-title":"Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics","volume":"203","author":"Lorenzer","year":"2015","journal-title":"J. Control. Rel."}],"container-title":["Handbook of Innovations in Central Nervous System Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978012818084600009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978012818084600009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T13:30:54Z","timestamp":1757683854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B978012818084600009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128180846"],"references-count":192,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-818084-6.00009-x","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}